coagulation

DEFINITION of coagulation

Coagulation is the complex, highly regulated physiological process by which liquid blood transforms into a solid gel (a clot or thrombus). It is the defining mechanism of secondary hemostasis, distinguishing itself from primary hemostasis (which only forms a temporary platelet plug) and agglutination (the clumping of particles like red blood cells due to antigen-antibody reactions, not fibrin formation). The underlying physiological mechanism is the coagulation cascade—a series of enzymatic reactions involving circulating clotting factors (via the intrinsic, extrinsic, and common pathways) that ultimately convert soluble fibrinogen into insoluble fibrin strands to stabilize the platelet plug. While essential physiologically to prevent life-threatening hemorrhage, it becomes pathological when triggered inappropriately inside intact vessels, causing thrombosis, or when widespread systemic activation depletes clotting factors, resulting in Disseminated Intravascular Coagulation (DIC, coded as D65). It is commonly confused with flocculation; however, coagulation in a medical context strictly refers to this enzymatic blood-clotting cascade, whereas flocculation is a reversible physical aggregation of suspended particles out of a solution.

---

ETYMOLOGY of coagulation

latin

Component	Origin	Meaning
coagulo- / coagul-	Latin coagulare (to curdle, clot), from cogere (to drive together)	“to curdle,” “to clot” — primary root referring to the solidification of a liquid
-ation	Latin -atio (-ationis)	Noun-forming suffix — “process of,” “state of,” “action of”

The word entered English in the early 15th century as coagulation (noun), borrowed from Middle French coagulation, from Latin coagulatio — literally “the process of curdling or clotting.” The root cogere (“to drive together”, from co- “together” + agere “to drive”) connects coagulation to the entire -coagul family: coagulant (an agent that promotes clotting), coagulopathy (a disease or defect of the clotting process), and anticoagulant (a substance that prevents clotting). The suffix -ation is highly productive in medical terminology for processes, appearing in terms like inflammation, fibrillation, and auscultation.

---

🔀 ALIASES / ALTERNATE TERMS

• Coagulative (adjective form — e.g., “coagulative necrosis,” “coagulative cascade”)
• Clotting (lay/clinical synonym — widely used in patient education and general clinical discourse)
• Secondary hemostasis (physiological synonym — the specific phase of bleeding control involving the fibrin cascade)
• Coagulopathy (disease state — an impairment or defect in the coagulation mechanism; e.g., D68.9)
• Hypercoagulability (pathological state — an abnormally increased tendency to form blood clots; e.g., D68.59)
• Disseminated Intravascular Coagulation (DIC) (systemic pathological form — widespread activation of clotting leading to factor depletion; D65)
• Argon plasma coagulation (APC) (procedural subtype — an endoscopic therapeutic technique using ionized argon gas to cauterize bleeding lesions)

---

🔗 RELATED TERMS

• Hemostasis — the broader physiological process of stopping bleeding, of which coagulation is the critical secondary phase.
• Thrombosis — the pathological manifestation of coagulation occurring inappropriately within an intact or relatively uninjured blood vessel.
• Agglutination — commonly confused with coagulation; the clumping of cells (like RBCs or bacteria) mediated by antibodies, not by the enzymatic fibrin formation of a true clot.
• Fibrinolysis — the physiological opposite of coagulation; the enzymatic breakdown of the fibrin clot by plasmin during tissue repair to restore vessel patency.
• Anticoagulation — the therapeutic use of medications (like heparin, warfarin, or DOACs) to intentionally inhibit the coagulation cascade in patients at risk for thrombosis.
• hemophilia — a specific genetic disease entity characterized by a severe deficiency in coagulation factors (e.g., Factor VIII in Hemophilia A, D66).

---

CODING CORNER

🏥 ICD-10-CM CODES

Coagulation Defects and Deficiencies (Bleeding Disorders)

Code	Description
D68.9	Coagulation defect, unspecified
D68.01	Von Willebrand disease, type 1
D68.1	Hereditary factor XI deficiency
D68.2	Hereditary deficiency of other clotting factors
D68.311	Acquired hemophilia
D68.32	Hemorrhagic disorder due to extrinsic circulating anticoagulants

Thrombophilia and Hypercoagulable States (Clotting Disorders)

Code	Description
D68.51	Activated protein C resistance (Factor V Leiden mutation)
D68.52	Prothrombin gene mutation
D68.59	Other primary thrombophilia
D68.61	Antiphospholipid syndrome

Severe Systemic Coagulation Disorders

Code	Description
D65	Disseminated intravascular coagulation [defibrination syndrome]
D66	Hereditary factor VIII deficiency (Hemophilia A)
D67	Hereditary factor IX deficiency (Hemophilia B)

---

🔧 COMMON CPT CODES (Coagulation-Related Labs & Procedures)

CPT Code	Description
85610	Prothrombin time (PT); evaluates the extrinsic and common pathways of coagulation
85730	Thromboplastin time, partial (PTT); plasma or whole blood; evaluates the intrinsic pathway
85379	Fibrin degradation products, D-dimer; quantitative
85240	Blood coagulation factor VIII, VW factor, ristocetin cofactor
43255	esophagogastroduodenoscopy, flexible, transoral; with control of bleeding, any method (e.g., via argon plasma coagulation)
45382	Colonoscopy, flexible; with control of bleeding, any method

---

⚠️ Coding Note: For inpatient profee and outpatient coding, highly specific documentation is required to accurately code coagulation disorders. When a patient presents with an abnormal bleeding tendency, look for documentation specifying whether the coagulopathy is congenital (e.g., hemophilia, VWD) or acquired (e.g., secondary to liver disease or anticoagulant medications). An undercoding alert: coders frequently default to “coagulation defect, unspecified” (D68.9), missing critical clinical triggers like “supratherapeutic INR on Warfarin,” which requires coding for the specific hemorrhagic disorder due to extrinsic anticoagulants (D68.32) as well as the appropriate adverse effect T-code. Additionally, if Disseminated Intravascular Coagulation (DIC) is documented, bill D65 and sequence it appropriately, often as a secondary diagnosis following the underlying trigger like sepsis, trauma, or malignancy. For CPT coding, basic surgical hemostasis/coagulation during a procedure is typically bundled into the primary surgery, but specific interventions for active GI bleeding (e.g., using thermal coagulation) elevate diagnostic endoscopies to therapeutic levels (e.g., 43255).

---

DERIVATIONS of coagulation

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(roots, (word) => econtains([[coagulation]].roots, word))) > 0 AND file.name != [[coagulation]].file.name
SORT file.name ASC

---

Query functionality

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(definition, (word) => econtains([[coagulation]].definition, word))) > 0 AND file.name != [[coagulation]].file.name

Med roots dictionary Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms